To evaluate the hormonal response to low blood sugar after a single oral dose of AZD1656 suspension.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
12
Research Site
Chula Vista, California, United States
Pharmacodynamic variables
Time frame: Blood samples taken repeatedly up to 6 hours during study days
Pharmacokinetic variables
Time frame: Blood samples taken repeatedly during 24 hours on study day sessions
Safety Variables (AEs, BP, pulse, electrocardiogram (ECG), hypoglycaemic symptoms and laboratory variables)
Time frame: Taken repeatedly during treatment periods
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.